These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 641812)

  • 1. Analysis of binding of daunorubicin and doxorubicin to DNA using computerized curve-fitting procedures.
    Bryn SR; Dolch GD
    J Pharm Sci; 1978 May; 67(5):688-93. PubMed ID: 641812
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction of daunorubicin and doxorubicin with DNA and chromatin.
    Zunino F; Di Marco A; Zaccara A; Gambetta RA
    Biochim Biophys Acta; 1980 Apr; 607(2):206-14. PubMed ID: 7370266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 4. Fate of DNA and its complexes with daunorubicin and adriamycin in rat fibroblasts [proceedings].
    Noël G; Trouet A
    Arch Int Physiol Biochim; 1977 Feb; 85(1):189-9. PubMed ID: 68743
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro.
    Schneider YJ; Baurain R; Zenebergh A; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):7-10. PubMed ID: 498422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-binding characteristics of aclarubicin as compared with daunorubicin and doxorubicin.
    Ando S; Kamiya K; Yoshimura T; Tsutani H; Ueda T; Uchida M; Nakamura T; Uchino H
    Anticancer Res; 1988; 8(3):409-15. PubMed ID: 3164610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous mixing experiments allow to determine the size of binding sites for anthracyclines complexed to DNA.
    Walter A
    Biomed Biochim Acta; 1985; 44(9):1321-7. PubMed ID: 3866577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin and daunorubicin disposition in the rabbit.
    Bachur NR; Hildebrand RC; Jaenke RS
    J Pharmacol Exp Ther; 1974 Nov; 191(2):331-40. PubMed ID: 4417723
    [No Abstract]   [Full Text] [Related]  

  • 9. Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells.
    Paul C; Peterson C; Gahrton G; Lockner D
    Cancer Chemother Pharmacol; 1979; 2(1):49-52. PubMed ID: 498420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectroscopic studies of the interaction of daunomycin with transfer RNA.
    Shafer RH
    Biochem Pharmacol; 1977 Sep; 26(18):1729-34. PubMed ID: 901591
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of new derivatives of daunorubicin and adriamycin with DNA.
    Arlandini E; Vigevani A; Arcamone F
    Farmaco Sci; 1977 May; 32(5):315-23. PubMed ID: 862886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of adriamycin and its beta anomer with DNA.
    Zunino F; Gambetta R; Di Marco A; Velcich A; Zaccara A; Quadrifoglio F; Crescenzi V
    Biochim Biophys Acta; 1977 May; 476(1):38-46. PubMed ID: 856282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells.
    Skovsgaard T
    Biochem Pharmacol; 1977 Feb; 26(3):215-22. PubMed ID: 14644
    [No Abstract]   [Full Text] [Related]  

  • 14. A hypothesis concerning possible new derivatives of daunorubicin and adriamycin with enhanced DNA-binding properties.
    Neidle S
    Cancer Treat Rep; 1977 Aug; 61(5):928-9. PubMed ID: 890699
    [No Abstract]   [Full Text] [Related]  

  • 15. Accumulation, metabolism and subcellular localization of daunorubicin, doxorubicin and their DNA-complexes in rat heart ventricles.
    Blanchard JC; Schneider YJ; Baurain R; Trouet A
    Eur J Cancer (1965); 1981 Mar; 17(3):297-305. PubMed ID: 7262167
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxyribonucleic acid binding.
    Sinha BK; Gregory JL
    Biochem Pharmacol; 1981 Sep; 30(18):2626-9. PubMed ID: 7306215
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Digoxin does not prevent daunorubicin or adriamycin from binding to rat heart muscle.
    Smith BJ; Kundv D
    Br J Cancer; 1976 Feb; 33(2):232-3. PubMed ID: 1259917
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration of chromatin structure induced by the binding of adriamycin, daunorubicin and ethidium bromide.
    Grimmond HE; Beerman T
    Biochem Pharmacol; 1982 Nov; 31(21):3379-86. PubMed ID: 7150361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin and daunorubicin bind in a cooperative manner to deoxyribonucleic acid.
    Graves DE; Krugh TR
    Biochemistry; 1983 Aug; 22(16):3941-7. PubMed ID: 6615810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equilibrium binding of daunomycin and adriamycin to calf thymus DNA. Temperature and ionic strength dependence of thermodynamic parameters.
    Barcelo F; Martorell J; Gavilanes F; Gonzalez-Ros JM
    Biochem Pharmacol; 1988 Jun; 37(11):2133-8. PubMed ID: 3377816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.